COR vs CVS · P/E 21, rev $321.33B vs P/E 16, rev $402.07B
Cencora Inc. (COR) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
COR currently screens at market cap $53.91B and trailing P/E 21.2. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the COR and CVS stock pages for the full models.
Not investment advice.